[Adoptive immunotherapy methods in ENT oncology].
The search for methods providing selective action on some subpopulations of immune system cells is an important task of oncologic immunology. Adaptive immunotherapy [AI] may create new options in this field. AI was used as adjuvant in combined therapy of 180 patients with ENT cancer. The response was confirmed by correction of some immunological, cytological, biochemical, immunochemical, radioimmunological, biophysical and rheological parameters. Practical guides are presented on AI use at different stages of combined treatment.